Vaccinex Short Long Term Debt Total from 2010 to 2024

VCNX Stock  USD 3.60  0.11  2.96%   
Vaccinex Short and Long Term Debt Total yearly trend continues to be fairly stable with very little volatility. Short and Long Term Debt Total will likely drop to about 234.7 K in 2024. During the period from 2010 to 2024, Vaccinex Short and Long Term Debt Total regression line of annual values had r-squared of  0.02 and arithmetic mean of  2,603,510. View All Fundamentals
 
Short and Long Term Debt Total  
First Reported
2017-12-31
Previous Quarter
122 K
Current Value
59 K
Quarterly Volatility
2.7 M
 
Covid
Check Vaccinex financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaccinex's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 19.7 K or Depreciation And Amortization of 181 K, as well as many indicators such as Price To Sales Ratio of 7.19, Dividend Yield of 0.0 or Days Sales Outstanding of 451. Vaccinex financial statements analysis is a perfect complement when working with Vaccinex Valuation or Volatility modules.
  
Check out the analysis of Vaccinex Correlation against competitors.
For more information on how to buy Vaccinex Stock please use our How to Invest in Vaccinex guide.

Latest Vaccinex's Short Long Term Debt Total Growth Pattern

Below is the plot of the Short Long Term Debt Total of Vaccinex over the last few years. It is Vaccinex's Short and Long Term Debt Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vaccinex's overall financial position and show how it may be relating to other accounts over time.
Short Long Term Debt Total10 Years Trend
Pretty Stable
   Short Long Term Debt Total   
       Timeline  

Vaccinex Short Long Term Debt Total Regression Statistics

Arithmetic Mean2,603,510
Geometric Mean1,257,388
Coefficient Of Variation133.30
Mean Deviation2,669,728
Median1,037,000
Standard Deviation3,470,609
Sample Variance12T
Range9M
R-Value0.15
Mean Square Error12.7T
R-Squared0.02
Significance0.59
Slope119,006
Total Sum of Squares168.6T

Vaccinex Short Long Term Debt Total History

2024234.7 K
2023247 K
2022485 K
2021390 K
20189.2 M
20172.8 M

About Vaccinex Financial Statements

Vaccinex investors use historical fundamental indicators, such as Vaccinex's Short Long Term Debt Total, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Vaccinex. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Short and Long Term Debt Total247 K234.7 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Vaccinex Stock Analysis

When running Vaccinex's price analysis, check to measure Vaccinex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaccinex is operating at the current time. Most of Vaccinex's value examination focuses on studying past and present price action to predict the probability of Vaccinex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaccinex's price. Additionally, you may evaluate how the addition of Vaccinex to your portfolios can decrease your overall portfolio volatility.